Compare SSTI & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSTI | RFL |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Real Estate |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.7M | 92.6M |
| IPO Year | 2017 | 2017 |
| Metric | SSTI | RFL |
|---|---|---|
| Price | $7.70 | $2.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 97.9K | ★ 183.8K |
| Earning Date | 05-14-2026 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,753,000.00 | $917,000.00 |
| Revenue This Year | $7.43 | N/A |
| Revenue Next Year | $6.25 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | 43.96 |
| 52 Week Low | $5.78 | $1.12 |
| 52 Week High | $16.20 | $2.50 |
| Indicator | SSTI | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 65.50 | 82.98 |
| Support Level | $6.16 | $1.23 |
| Resistance Level | $8.29 | N/A |
| Average True Range (ATR) | 0.43 | 0.18 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 71.05 | 84.58 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes: ShotSpotter, the acoustic gunshot detection system; CrimeTracer, the foremost law enforcement search engine; CaseBuilder, a one-stop investigation management system; ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact; PlateRangerTM powered by Rekor, an automatic license plate recognition ("ALPR") and vehicle identification solution; SafePointe, an AI-based weapons detection system.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.